EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis

Figure 2 Kaplan-Meier survival curves for 119 CRC patients categorized by EZH2 and/or STAT6 expression. A: Survival was significantly lower in patients with positive EZH2 expression than in those with negative expression (P = 0.02); B: Survival was significantly lower in patients with positive STAT6 expression than in those with negative expression (P = 0.005); C: Patients with EZH2+/STAT6+ expression profiles had worse survival outcome (P = 0.006).